Lok Sabha Question No. 2185 (UNSTARRED), answered on 2022-07-29
Subject: Indigenous Medicines of Ayush
Ministry: AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)
Asked by: D. M. Kathir Anand

## GOVERNMENT OF INDIA MINISTRY OF AYUSH

## LOK SABHA UNSTARRED QUESTION NO. 2185 TO BE ANSWERED ON 29 TH  JULY, 2022

## 'INDIGENOUS MEDICINES OF AYUSH'

## 2185.  SHRI D.M. KATHIR ANAND:

Will the Minister of AYUSH be pleased to state:

- a) whether  the  Government  has  recognised  the  indigenous  medicines  of  Ayush  for  the treatment and cure for various types of Cancer, Liver and Kidney ailments;
- b) if so, the details thereof and the current list of approved Ayush Medicines;
- c) whether the Government has taken adequate measures to provide approval for life saving medicines; and
- d) if so, the detailed list of Ayush medicines registered for approval, got approved, rejected and pending approval in the last five years?

## ANSWER THE MINISTER OF AYUSH (SHRI SARBANANDA SONOWAL)

(a)  and  (b)  Yes  Sir,  Ministry  of  Ayush,  Government  of  India  has  recognized  the indigenous  medicines  of  Ayush  for  the  treatment  for  various  types  ailments  including Cancer, Liver and Kidney ailments.

Central  Council  for  Research  in  Ayurvedic  Sciences  (CCRAS)  has  undertaken clinical  studies  in  improving quality of life in cancer patients and in high grade serous epithelial  ovarian  cancer  at  first  serological  relapse  besides  documentation  of  Cancer treatment practices. Further, CCRAS has also undertaken various clinical studies in the field of cancer, Liver and kidney diseases. The details are at Annexure -I .

All India Institute of Ayurveda under Ministry of Ayush is running specialty clinic in  Nephrology,  Integrative  Cancer  Care  &  Gastrointestinal  disorders  and  using  the classical  Ayurveda  preparations  for  managing  these  cases,  based  on  the  principles  of Ayurveda. Ministry of Ayush has published National List of Essential AYUSH Medicines (NLEAM)  in  January,  2022.  It  comprises  of  essential  Ayurveda,  Unani, Siddha  and  Homoeopathic  medicines  along  with  their  reference  text,  main  disease indications, dose, precaution/ contraindication. (c) and (d) There is no separate category  of 'life saving medicines' for Ayush system of

medicine.

*******

## Annexure-I

Details of Research studies undertaken by the Council in  Cancer, Liver and Kidney ailments -

-  Ayush QOL2C  for improving quality of life in cancer patients.
-  A phase II trial to study efficacy, toxicity and immunomodulatory effect of Carctol-S in high grade serous epithelial ovarian cancer at first serological relapse : Ongoing
-  A Cross sectional study of Cancer KAP among Ayurveda and Allopathic fraternity.
-  Ayurveda  Interventions  for  Cancer:  Systematic  Review,  Meta-analysis;  and  Revival, Documentation, Validation and analysis of data from practitioners, institutes  : Ongoing
-  Assessment  of  Prakriti  (Ayurvedic  body  constitution)  of  patients  with  Cervical  and Ovarian cancers  : Ongoing
-  Screening of medicinal plants on Anticancer Activity.
-  Clinical efficacy of Goksura churna and Sveta parpati in the Management of Mutrasmari (Urolithiasis).
-  Clinical  evaluation  of  Shvadamstradi  Kashaya  and  Hajarulayahud  Bhasma  in  the management of Mutrasmari (Urolithiasis).
-  Clinical Evaluation of the Efficacy of Varunadi Kwatha and Chandraprabha Vati in the management of Mutrasmari (Urolithiasis): Ongoing
-  Clinical Evaluation of Varunadi Kwath Churna and Apamarga Kshara in the management of Mutrashmari (urolithiasis):Ongoing
-  Clinical efficacy and safety of Arogyavardhini Vati and Pippalyadasava in the management of Non-Alcoholic Fatty Liver Disease (NAFLD)- An open label prospective clinical trial : Ongoing
-  Evaluation of Ayush-GMH in the subjects of mild to moderate Non alcoholic fatty liver disease (NAFLD)-A double blind randomized control clinical study : Ongoing
-  Evaluation of Hepatoprotective activity of PTK as an add on therapy in the patients of Tuberculosis on ATT - A Double Blind Randomized control clinical study : Ongoing